Neurologix, Inc. to Present at Sachs Associates - Bloomberg L.P.'s 6th Annual North America Forum

FORT LEE, N.J.--(BUSINESS WIRE)--Neurologix, Inc. (OTCBB: NRGX), a biotech company engaged in the development of innovative gene therapies for the brain and central nervous system, today announced that John E. Mordock, president and chief executive officer of the Company, will present at the Sachs Associates’ 6th Annual North America Forum to be held March 12, 2007, in Boston, Massachusetts.

MORE ON THIS TOPIC